Stocks He Just Talked About. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) ...

Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued ...

Thermo Fisher perfectly rode the tidal wave of demand for health care that came during the pandemic. The company experienced ...

During the pandemic, spending on diagnostics and vaccine research skyrocketed, and one of the main beneficiaries was Thermo ...

Thermo Fisher's TMO Bioproduction business prospects look promising. Strategic buyouts and partnerships are likely to drive ...

Thermo Fisher Scientific was founded in 1956 and ... to an increase in domestic income as well as the industry's new products and low prices.

Thermo Fisher launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to enhance cell therapy development and production.

Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 ...

While the pandemic has increased demand for Thermo Fisher products and services, the demand for testing is a question mark. "Nobody knows what demand for testing will be next year," Caspar said.

In a report released on December 8, Conor McNamara from RBC Capital maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a ...

Thermo Fisher acquired PPD for $17.4 billion in 2021 ... predictive modeling in early development of services and drug products,” Kane said. “We have utilized machine learning, artificial ...